Further results from the MASTER DAPT trial of abbreviated dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in patients at high bleeding risk stratified by use of oral ...

Munich, Germany - 28 Aug 2018: Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients ...

Background: The use of antiplatelet therapy in combination with oral anticoagulants remains controversial. The objective of this study was to estimate and compare the incidence of adverse and coronary ...

Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients without a clear indication for ...

Two common medications that are categorized as blood thinners and used to prevent blood clots are anticoagulants and antiplatelets. Both are essential in treating conditions caused by blood clots such ...

Patients with atrial fibrillation who took oral anticoagulants alone after undergoing transcatheter aortic valve replacement (TAVR) had a lower rate of bleeding complications without an increased risk ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Antiplatelet or ...

For patients with atrial fibrillation who undergo TAVR, being discharged on antiplatelet therapy seems key in reducing the risk of stroke at 2 years, according to post hoc analysis of PARTNER II data.

In a randomized trial, adding an antiplatelet to anticoagulant therapy in patients with ischemic stroke, nonvalvular atrial fibrillation, and atherosclerosis provided no significant benefit. There was ...

Anticoagulant or antiplatelet drugs, sometimes called blood thinners, help prevent blood clots. There are many options, including heparin and warfarin. Preventing clots reduces the risk of stroke and ...

Please provide your email address to receive an email when new articles are posted on . The multitarget stool DNA test had a positive predictive value of 31.4% for detecting advanced adenomas.